Neo Medical secures USD 68 million to expand its AI-powered spine surgery platform
24 September 2024
Neo Medical has raised USD 68 million in a Series B financing round to accelerate the global growth of its AI-driven spine surgery solutions, with a focus on the US market.
Neo Medical, a Lausanne-based medtech company specializing in spine surgery, has successfully completed a USD 68 million Series B financing round. Led by Gyrus Capital SA, alongside existing investors like Swisscom Ventures and Credit Suisse Entrepreneur Capital, this significant investment will support the global expansion of Neo Medical’s innovative technologies.
Since its commercial launch in 2016, Neo Medical has developed a comprehensive spine surgery platform that integrates artificial intelligence (AI) and augmented reality (AR) with specialized surgical hardware. The company’s ADVISE platform provides real-time intraoperative data, enabling surgeons to deliver personalized spine treatments. Neo Medical’s technologies have been used to treat approximately 36,000 patients and have demonstrated significant clinical benefits, including reduced operative times and lower implant failure rates.
CEO and Co-Founder Vincent Lefauconnier emphasized the importance of innovation in the thoracolumbar spine surgery market: “This sector has lacked disruptive innovation for decades. With Neo Universa™, we are introducing a platform that delivers real value both inside and outside the operating room.”
Proceeds from this round will be used to increase Neo Medical’s market share, particularly in the U.S., and to develop new products that enhance the ADVISE platform. Neo Medical’s success reflects the growing demand for advanced surgical technologies in the USD 7.6 billion thoracolumbar fusion market.